GLP-1 RECEPTOR AGONIST AND USE THEREOF
The present invention provides novel compounds of chemical formula 1, optical isomers of the compounds, or a pharmaceutically acceptable salts of the compounds, or the optical isomers. The compounds, isomers, and salts exhibits excellent activity as GLP-1 receptor agonists. Particularly, they, as GLP-1 receptor agonists, exhibit excellent glucose tolerance, thus having a great potential to be used therapeutic agents for metabolic diseases. In addition, they exhibits excellent pharmacological safety for cardiovascular systems..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Europäisches Patentamt - (2023) vom: 01. Nov. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
YOON HONG CHUL [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-11-01, Last update posted on www.tib.eu: 2024-03-05, Last updated: 2024-03-08 |
|---|
| Patentnummer: |
EP4059929 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA015231240 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA015231240 | ||
| 003 | DE-627 | ||
| 005 | 20240308100837.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230216s2023 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA015231240 | ||
| 035 | |a (EPA)EP4059929 | ||
| 035 | |a (EPA)75913064 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a YOON HONG CHUL |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a GLP-1 RECEPTOR AGONIST AND USE THEREOF |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2023-11-01, Last update posted on www.tib.eu: 2024-03-05, Last updated: 2024-03-08 | ||
| 520 | |a The present invention provides novel compounds of chemical formula 1, optical isomers of the compounds, or a pharmaceutically acceptable salts of the compounds, or the optical isomers. The compounds, isomers, and salts exhibits excellent activity as GLP-1 receptor agonists. Particularly, they, as GLP-1 receptor agonists, exhibit excellent glucose tolerance, thus having a great potential to be used therapeutic agents for metabolic diseases. In addition, they exhibits excellent pharmacological safety for cardiovascular systems. | ||
| 650 | 4 | |a C07D: Heterocyclic compounds (macromolecular compounds c08) | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a AN KYUNG MI |4 aut | |
| 700 | 0 | |a LEE MYONG JAE |4 aut | |
| 700 | 0 | |a LEE JIN HEE |4 aut | |
| 700 | 0 | |a KIM JEONG-GEUN |4 aut | |
| 700 | 0 | |a IM A-RANG |4 aut | |
| 700 | 0 | |a JEON WOO JIN |4 aut | |
| 700 | 0 | |a JEONG JIN AH |4 aut | |
| 700 | 0 | |a HEO JAEHO |4 aut | |
| 700 | 0 | |a HONG CHANGHEE |4 aut | |
| 700 | 0 | |a KIM KYEOJIN |4 aut | |
| 700 | 0 | |a PARK JUNG-EUN |4 aut | |
| 700 | 0 | |a SOHN TE-IK |4 aut | |
| 700 | 0 | |a OH CHANGMOK |4 aut | |
| 700 | 0 | |a HONG DA HAE |4 aut | |
| 700 | 0 | |a KWON SUNG WOOK |4 aut | |
| 700 | 0 | |a KIM JUNG HO |4 aut | |
| 700 | 0 | |a SHIN JAE EUI |4 aut | |
| 700 | 0 | |a YOO YEONGRAN |4 aut | |
| 700 | 0 | |a CHANG MIN WHAN |4 aut | |
| 700 | 0 | |a JANG EUN HYE |4 aut | |
| 700 | 0 | |a JE IN-GYU |4 aut | |
| 700 | 0 | |a CHOI JI HYE |4 aut | |
| 700 | 0 | |a KIM GUNHEE |4 aut | |
| 700 | 0 | |a JUN YEARIN |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 01. Nov. |
| 773 | 1 | 8 | |g year:2023 |g day:01 |g month:11 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/75913064/publication/EP4059929A1?q=EP4059929 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 01 |c 11 | ||